TLR9 and plasma cell myeloma: The oncogenic effect has also been reported for TLR7 and TLR9 in the myeloma cells, where the aberrant expression of such receptors prevents chemotherapy‐induced apoptosis through promoting the autocrine secretion of IL‐6.37, 48